Brief: Biostage announces $5 million at-the-market offering
16/05/2016 14:00
May 16 (Reuters) - Biostage announces $5 million
at-the-market offering BSTG.O
* Says will issue approximately 2.8 million registered
shares of common stock at a purchase price of $1.7625 per share
* Intends to use proceeds for research and development and
advancing Biostage's Cellframe technology
Source text for Eikon: ID:nPn5fnJh8a
Further company coverage: BSTG.O
(Bengaluru Newsroom: +1 646 223 8780)
Recent news on Harvard Apparatus Regenerative Technology
See all newsBrief: Harvard Apparatus Regenerative Technology Announces Strategic Collaboration With Children’S Hospital Capital Institute Of Pediatrics In Beijing, China To Advance Treatment For Esophageal Atresia
Brief: Biostage Activated Mayo Clinic As The First Site For Clinical Trial In Severe Esophageal Disease
Brief: Biostage Amends CEO Employment Agreement
Brief: Biostage Inc Files For Firm Commitment Public Offering Of 1.03 Million Units - SEC Filing
Brief: Biostage Announces Appointment Of New Chief Financial Officer